These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 34562673)
21. Umbelliferone derivatives exert neuroprotective effects by inhibiting monoamine oxidase A, self-amyloidβ aggregation, and lipid peroxidation. Seong SH; Ali MY; Jung HA; Choi JS Bioorg Chem; 2019 Nov; 92():103293. PubMed ID: 31557622 [TBL] [Abstract][Full Text] [Related]
22. Potent and selective inhibition of human monoamine oxidase-B by 4-dimethylaminochalcone and selected chalcone derivatives. Oh JM; Kang MG; Hong A; Park JE; Kim SH; Lee JP; Baek SC; Park D; Nam SJ; Cho ML; Kim H Int J Biol Macromol; 2019 Sep; 137():426-432. PubMed ID: 31271801 [TBL] [Abstract][Full Text] [Related]
23. Pyridoxine-resveratrol hybrids as novel inhibitors of MAO-B with antioxidant and neuroprotective activities for the treatment of Parkinson's disease. Li W; Yang X; Song Q; Cao Z; Shi Y; Deng Y; Zhang L Bioorg Chem; 2020 Apr; 97():103707. PubMed ID: 32146176 [TBL] [Abstract][Full Text] [Related]
24. Identification of Indole-Based Chalcones: Discovery of a Potent, Selective, and Reversible Class of MAO-B Inhibitors. Sasidharan R; Manju SL; Uçar G; Baysal I; Mathew B Arch Pharm (Weinheim); 2016 Aug; 349(8):627-37. PubMed ID: 27373997 [TBL] [Abstract][Full Text] [Related]
25. Osthenol, a prenylated coumarin, as a monoamine oxidase A inhibitor with high selectivity. Baek SC; Kang MG; Park JE; Lee JP; Lee H; Ryu HW; Park CM; Park D; Cho ML; Oh SR; Kim H Bioorg Med Chem Lett; 2019 Mar; 29(6):839-843. PubMed ID: 30686752 [TBL] [Abstract][Full Text] [Related]
26. Synthesis of some novel hydrazone and 2-pyrazoline derivatives: monoamine oxidase inhibitory activities and docking studies. Evranos-Aksöz B; Yabanoğlu-Çiftçi S; Uçar G; Yelekçi K; Ertan R Bioorg Med Chem Lett; 2014 Aug; 24(15):3278-84. PubMed ID: 24986657 [TBL] [Abstract][Full Text] [Related]
27. Discovery of coumarin Mannich base derivatives as multifunctional agents against monoamine oxidase B and neuroinflammation for the treatment of Parkinson's disease. Tao D; Wang Y; Bao XQ; Yang BB; Gao F; Wang L; Zhang D; Li L Eur J Med Chem; 2019 Jul; 173():203-212. PubMed ID: 31005056 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and evaluation of biaryl derivatives for structural characterization of selective monoamine oxidase B inhibitors toward Parkinson's disease therapy. Yeon SK; Choi JW; Park JH; Lee YR; Kim HJ; Shin SJ; Jang BK; Kim S; Bahn YS; Han G; Lee YS; Pae AN; Park KD Bioorg Med Chem; 2018 Jan; 26(1):232-244. PubMed ID: 29198609 [TBL] [Abstract][Full Text] [Related]
29. Ethyl Acetohydroxamate Incorporated Chalcones: Unveiling a Novel Class of Chalcones for Multitarget Monoamine Oxidase-B Inhibitors Against Alzheimer's Disease. Reeta ; Baek SC; Lee JP; Rangarajan TM; Ayushee ; Singh RP; Singh M; Mangiatordi GF; Nicolotti O; Kim H; Mathew B CNS Neurol Disord Drug Targets; 2019; 18(8):643-654. PubMed ID: 31550216 [TBL] [Abstract][Full Text] [Related]
30. Novel 2H-chromen-2-one derivatives of resveratrol: Design, synthesis, modeling and use as human monoamine oxidase inhibitors. Ruan BF; Cheng HJ; Ren J; Li HL; Guo LL; Zhang XX; Liao C Eur J Med Chem; 2015 Oct; 103():185-90. PubMed ID: 26352677 [TBL] [Abstract][Full Text] [Related]
31. Novel tricyclic pyrazolo[1,5-d][1,4]benzoxazepin-5(6H)-one: Design, synthesis, model and use as hMAO-B inhibitors. Chen R; Xiao J; Ni Y; Xu HF; Zheng M; Tong X; Zhang TT; Liao C; Tang WJ Bioorg Med Chem; 2016 Apr; 24(8):1741-8. PubMed ID: 26964672 [TBL] [Abstract][Full Text] [Related]
32. Discovery of New Chemical Entities for Old Targets: Insights on the Lead Optimization of Chromone-Based Monoamine Oxidase B (MAO-B) Inhibitors. Reis J; Cagide F; Chavarria D; Silva T; Fernandes C; Gaspar A; Uriarte E; Remião F; Alcaro S; Ortuso F; Borges F J Med Chem; 2016 Jun; 59(12):5879-93. PubMed ID: 27244485 [TBL] [Abstract][Full Text] [Related]
33. Design, Synthesis and hMAO Inhibitory Screening of Novel 2-Pyrazoline Analogues. Evranos-Aksoz B; Ucar G; Yelekci K Comb Chem High Throughput Screen; 2017; 20(6):510-521. PubMed ID: 28474546 [TBL] [Abstract][Full Text] [Related]
34. Neuroprotective effects of benzyloxy substituted small molecule monoamine oxidase B inhibitors in Parkinson's disease. Wang Z; Wu J; Yang X; Cai P; Liu Q; Wang KDG; Kong L; Wang X Bioorg Med Chem; 2016 Nov; 24(22):5929-5940. PubMed ID: 27692996 [TBL] [Abstract][Full Text] [Related]
35. Discovery of benzamide-hydroxypyridinone hybrids as potent multi-targeting agents for the treatment of Alzheimer's disease. Jiang X; Guo J; Zhang C; Gu J; Zhou T; Bai R; Xie Y J Enzyme Inhib Med Chem; 2021 Dec; 36(1):2045-2054. PubMed ID: 34607518 [TBL] [Abstract][Full Text] [Related]
36. Coumarin-Rasagiline Hybrids as Potent and Selective hMAO-B Inhibitors, Antioxidants, and Neuroprotective Agents. Matos MJ; Herrera Ibatá DM; Uriarte E; Viña D ChemMedChem; 2020 Mar; 15(6):532-538. PubMed ID: 32037726 [TBL] [Abstract][Full Text] [Related]
37. (Pyrrolo-pyridin-5-yl)benzamides: BBB permeable monoamine oxidase B inhibitors with neuroprotective effect on cortical neurons. Tzvetkov NT; Stammler HG; Hristova S; Atanasov AG; Antonov L Eur J Med Chem; 2019 Jan; 162():793-809. PubMed ID: 30522087 [TBL] [Abstract][Full Text] [Related]
38. Asymmetric synthesis, molecular modeling and biological evaluation of 5-methyl-3-aryloxazolidine-2,4-dione enantiomers as monoamine oxidase (MAO) inhibitors. Erol Gunal S; Teke Tuncel S; Gokhan Kelekci N; Ucar G; Yuce Dursun B; Sag Erdem S; Dogan I Bioorg Chem; 2018 Apr; 77():608-618. PubMed ID: 29501028 [TBL] [Abstract][Full Text] [Related]
39. (E)-3-Heteroarylidenechroman-4-ones as potent and selective monoamine oxidase-B inhibitors. Desideri N; Proietti Monaco L; Fioravanti R; Biava M; Yáñez M; Alcaro S; Ortuso F Eur J Med Chem; 2016 Jul; 117():292-300. PubMed ID: 27135371 [TBL] [Abstract][Full Text] [Related]
40. Synthesis, in vitro, and in silico studies of new derivatives of diphenylpiperazine scaffold: A key substructure for MAO inhibition. El-Halaby LO; El-Husseiny WM; El-Messery SM; Goda FE Bioorg Chem; 2024 Feb; 143():107011. PubMed ID: 38061181 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]